These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 725180)

  • 21. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
    Forrest WA
    Br J Clin Pract; 1972 May; 26(5):217-22. PubMed ID: 4625606
    [No Abstract]   [Full Text] [Related]  

  • 22. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of acebutolol in angina pectoris with ergometric evaluation].
    Beugin JP; Caux G; Gamblin J; Bisch JF; Cornaert P; Dutoit A; Croccel L
    LARC Med; 1982 May; 2(5):456-8. PubMed ID: 7167022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and ergometric evaluation of diltiazem in the treatment of angina pectoris].
    Lage Bouzamayor B; Eguileta Martínez T; Zubizarreta Alberdi R; González Juanatey JR; Gil de la Peña M
    Med Clin (Barc); 1988 Nov; 91(18):685-9. PubMed ID: 3230985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulatory and electrocardiographic effects of oxprenolol in angina pectoris.
    Sharma B; Majid PA; Galvin MC; Taylor SH
    Postgrad Med J; 1970 Nov; ():Suppl:72-6. PubMed ID: 4395463
    [No Abstract]   [Full Text] [Related]  

  • 27. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow release oxprenolol in angina pectoris [proceedings].
    Goldstraw PW; Taylor SH; Thadani U; Watt SJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of Trasicor and hypothiazide in the treatment of hypertension and hypertensive angina pectoris.
    Antalóczy Z
    Ther Hung; 1975; 23(3):118-21. PubMed ID: 1209524
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects and duration of the action of nifedipine tablets (20 mg). Ergometric evaluation in double-blind studies with a placebo].
    Gibelli G; Carnovali M; Orvieni C; Colombo G; Castelli D; De Vita C
    Minerva Cardioangiol; 1982; 30(7-8):387-94. PubMed ID: 6752751
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxoprenolol in angina pectoris.
    Lewis BS; Bakst A; Gotsman MS
    S Afr Med J; 1972 Aug; 46(34):1209-14. PubMed ID: 5056770
    [No Abstract]   [Full Text] [Related]  

  • 32. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
    Forrest WA
    Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA; Yanovskii GV; Lizogub VG
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantification pitfalls in comparative studies of antianginal therapies.
    Tremblay G; Biron P; Proulx A
    Am Heart J; 1975 Apr; 89(4):521-5. PubMed ID: 803767
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic efficacy of prostacyclin in the patients with effort angina--evaluation by treadmill exercise test].
    Yamamoto M; Saito S; Tsuji M; Moriuchi M; Tamura Y; Tanigawa N; Ozawa Y; Hatano M
    Kokyu To Junkan; 1984 Feb; 32(2):185-9. PubMed ID: 6379793
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
    Papa M; Acanfora D; Artiaco D; Santangelo L; Covelluzzi F; De Rosa ML; Cicatiello M; De Caprio L; Rengo F
    G Ital Cardiol; 1987 Apr; 17(4):344-50. PubMed ID: 3653591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perhexiline maleate. Clinical results. Exercise tests using the ergometric bicycle].
    Gilgenkrantz JM; Aliot E; Niederlander G; Maureira JJ
    Ann Cardiol Angeiol (Paris); 1976; 25(4):303-9. PubMed ID: 782332
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of spontaneous and effort angina with nifedipine].
    Valle Tudela V; Alijarde Guimera M; Cortadellas Angel MJ; Ríus Garriga J; Soler Soler J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II53-60. PubMed ID: 7170408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.